{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jalencas X"],"funding":["Norges Forskningsråd","Ministerio de Ciencia, Innovación y Universidades","Helse Vest","European Regional Development Fund"],"pagination":["1176-1188"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11042166"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(4)"],"pubmed_abstract":["The EU-OPENSCREEN (EU-OS) European Research Infrastructure Consortium (ERIC) is a multinational, not-for-profit initiative that integrates high-capacity screening platforms and chemistry groups across Europe to facilitate research in chemical biology and early drug discovery. Over the years, the EU-OS has assembled a high-throughput screening compound collection, the European Chemical Biology Library (ECBL), that contains approximately 100 000 commercially available small molecules and a growing number of thousands of academic compounds crowdsourced through our network of European and non-European chemists. As an extension of the ECBL, here we describe the computational design, quality control and use case screenings of the European Fragment Screening Library (EFSL) composed of 1056 mini a"],"journal":["RSC medicinal chemistry"],"pubmed_title":["Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection."],"pmcid":["PMC11042166"],"funding_grant_id":["1.1.1.1/19/A/019","245828","273588","F-12602","PID2020-112539RB-I00","245922"],"pubmed_authors":["Yadrykhinsky V","Zaliani A","Brenk R","Berg H","Harmel R","Georgiou C","Jirgensons A","Specker E","Gribbon P","Jaudzems K","Mestres J","Richter C","Miletic T","Kinnen F","Espeland LO","Schwalbe H","Jalencas X","Sreeramulu S"],"additional_accession":[]},"is_claimable":false,"name":"Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection.","description":"The EU-OPENSCREEN (EU-OS) European Research Infrastructure Consortium (ERIC) is a multinational, not-for-profit initiative that integrates high-capacity screening platforms and chemistry groups across Europe to facilitate research in chemical biology and early drug discovery. Over the years, the EU-OS has assembled a high-throughput screening compound collection, the European Chemical Biology Library (ECBL), that contains approximately 100 000 commercially available small molecules and a growing number of thousands of academic compounds crowdsourced through our network of European and non-European chemists. As an extension of the ECBL, here we describe the computational design, quality control and use case screenings of the European Fragment Screening Library (EFSL) composed of 1056 mini a","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Apr","modification":"2026-06-02T01:43:21.487Z","creation":"2026-04-13T03:12:24.124Z"},"accession":"S-EPMC11042166","cross_references":{"pubmed":["38665834"],"doi":["10.1039/d3md00724c"]}}